Clinical Trial Update: High Dose Sequential Therapy and Autologous Stem Cell Rescue for Multiple Myeloma [Phase 2]

View source ↗

Summary

A Phase 2 trial at Duke University evaluating high-dose sequential therapy with autologous stem cell rescue for multiple myeloma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Snippet

Sponsor: Duke University | Conditions: Multiple Myeloma | Phase 2 | Status: COMPLETED